Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS - Wikidata - awgldk - TriplyDB

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS

http://www.wikidata.org/entity/Q37531460

about

What we know and do not know about the cannabinoid receptor 2 (CB2)Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection Pathogenesis of Systemic Sclerosis.Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages.Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats.Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.Medical cannabis: Another piece in the mosaic of autoimmunity?Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation.Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia.Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn's Disease.A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers.Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

P2860

Q27686851-6DE22D12-BD73-4E99-8161-19F68605FF15 Q28082891-AAF785B5-9E46-451C-9568-A46B72CE4754 Q35499568-7706E916-2EA9-43A2-A0B0-2D3E8DD295A7 Q35693212-21EB3480-61D5-4FAF-AF0E-69BEC85FB45A Q35731427-4F7A2867-F883-4CFD-A9A3-8C022FE5EF1D Q35752103-D5087420-D558-49C7-92AF-2C3F9A367C3F Q36128488-D76DAC5D-2213-46F5-81DE-C17C3CDFDF43 Q37648708-57FF045E-8E58-4F99-A929-FACD12968E60 Q38324480-7BDDE51A-9BF5-42D1-98E6-EA64E41F077F Q38771463-8B1B1327-D500-447A-81DE-BB1E7C1AE809 Q39004244-4E5178F5-6EBB-4157-9737-265540CDD944 Q39012168-82B6A120-B681-42A8-8894-D8E51E7DA196 Q41486650-5BFAD9EC-3B80-4439-94D7-7EF3AA6CE437 Q41864447-0B03F056-6DC3-42F6-9D8A-CDD235AC677B Q45288114-C14D2EBE-CCDC-4C35-871A-30EC6F2F38DE Q49391796-88E527E3-0B72-438A-B976-E45EDE73315F Q49579501-5F6CE27F-6668-4250-8765-BB6644AF4E81 Q50013540-B9E6BFEE-8475-4034-B91B-B423F46F8863 Q52678835-F34CC42C-1960-4354-A3B4-1B55466CE5A3 Q58720052-43E7CD02-A6D9-4867-A53E-5CC2D5C5CB64 Q58775742-3E051E9C-D599-40C4-BAC8-2E85B03F622A

P2860

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS

http://www.wikidata.org/entity/Q37531460

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Selective CB2 receptor activat ...... e cell accumulation in the CNS

@en

Selective CB2 receptor activat ...... cell accumulation in the CNS.

@nl

type

label

Selective CB2 receptor activat ...... e cell accumulation in the CNS

@en

Selective CB2 receptor activat ...... cell accumulation in the CNS.

@nl

prefLabel

Selective CB2 receptor activat ...... e cell accumulation in the CNS

@en

Selective CB2 receptor activat ...... cell accumulation in the CNS.

@nl

P1433

Q37531460-3C46F108-59AE-4950-B1E2-77C9409D6DB0

P1476

Q37531460-20735A4E-7A13-457C-A3F7-D193896F169B

P2093

Q37531460-11437AFB-F5D2-4373-B10A-D82B6A5B3413

Q37531460-1594CBD1-FE7B-412D-9507-DF89889A5369

Q37531460-2B83C03B-BB45-4F94-9ECB-B148171AA614

Q37531460-801D049A-8A10-4DC6-8396-539A143A4A81

P2860

Q37531460-03EC07F0-4C9E-452D-B3A0-01EA31862383

Q37531460-09C5E199-1C35-46BA-8F39-8F0119BC70DF

Q37531460-0EAB6C18-37E1-4F99-8015-995B976A5D05

Q37531460-1887E96C-2ED9-4758-A117-368C7C14F3BB

Q37531460-1D5CEB49-7DE7-43EC-B351-769D3616CEF9

Q37531460-214EE74C-2CA7-4C73-A9CC-94E406645902

Q37531460-22316DD6-E92D-42AF-A2E5-9695AAB97B6B

Q37531460-2CBB4D65-FBE3-401D-A869-4279C00632A8

Q37531460-2DA89698-7B58-42E7-A900-EE1BD012A125

Q37531460-354E9793-A6D1-451A-B6AD-7E77EB862892

P304

Q37531460-1E65EBCD-6CEF-40C2-8408-A549892E3DF5

P31

Q37531460-21D0A21A-59ED-44BA-A886-3C0CAC4034EE

P356

Q37531460-81520F8D-EB56-4C57-A49F-79D2E4F859FA

P433

Q37531460-045F504E-EB5C-4080-B470-9B3383F604FF

P478

Q37531460-EAA0FFFA-5246-4AF6-8E36-519F730659D2

P577

Q37531460-04FD03FD-E5F0-45A1-9309-4005B8A7F4D1

P698

Q37531460-16D171C6-96AA-4F09-B4D4-B01CB5937C7E

P932

Q37531460-50C06559-9CE3-44D0-A50D-090FB4462A90

P356

J.CELLIMM.2013.11.002

P1433

Cellular Immunology

P1476

Selective CB2 receptor activat ...... e cell accumulation in the CNS

@en

P2093

Doina Ganea

http://www.w3.org/2001/XMLSchema#string

Hongbo Li

http://www.w3.org/2001/XMLSchema#string

Ronald F Tuma

http://www.w3.org/2001/XMLSchema#string

Weimin Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Multiple sclerosis

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.

Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.

P304

1-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELLIMM.2013.11.002

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24342422

http://www.w3.org/2001/XMLSchema#string

P932

3906668

http://www.w3.org/2001/XMLSchema#string